<DOC>
	<DOCNO>NCT00098358</DOCNO>
	<brief_summary>Tissue inflammation major component acne disease process . Leukotriene B4 ( LTB4 ) think major player development tissue inflammation . Synthesis LTB4 control enzyme 5-lipoxygenase . Zileuton block activity 5-lipoxygenase . This study test safety efficacy zileuton treatment facial acne .</brief_summary>
	<brief_title>Study Oral Zileuton Treatment Moderate Severe Facial Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Zileuton</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Moderate severe facial acne vulgaris 20 60 facial inflammatory lesion 10 200 facial noninflammatory lesion No 3 facial nodular cystic lesion Uncontrolled systemic disease Use systemic topical acne therapy within 14 day study Use systemic retinoids within past 2 year Skin diseases interfere acne count Active liver disease Screening elevation liver function test Positive serology hepatitis B C Use theophylline , warfarin , propranolol within 7 day study Use Singulair Accolate within 14 day study Female patient pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Leukotrienes</keyword>
	<keyword>inflammation</keyword>
</DOC>